Government Relations

With a new year, new Congress, and new presidential administration well underway, pundits and politicians alike continue to opine on what the future of healthcare should look like for the [...]

The concurrent effects of the novel coronavirus and sweeping demands for racial equity are, arguably, creating the greatest social disruption America has witnessed in the last 50 years. While the [...]

How can our health care system continue to push the envelope by developing breakthrough medicines, yet still meet the needs of patients with treatments they can afford? Midterm elections are [...]

As we near the 2019 mid-term elections, pundits and prognosticators are focusing on what the make-up of Congress will look like in 2019 and what it means for President Trump’s agenda. Yet, for [...]

To drive meaningful change in health in the UK is challenging, as I am sure it is across the world. It requires a clarity of purpose and evidence, a wide range of engaged stakeholders and [...]

Initial analysis from JPA Health What will health policy look like during the Trump Administration? Trying to understand what President-elect Trump will do about healthcare—an area in which he [...]

Patients and advocacy groups may be one step closer to increasing the strength of their voices in the development of new treatments. A bill designed to spur biomedical innovation and place [...]

Some of the buzzwords surrounding healthcare for 2014, so far: eHealth, telemedicine, wireless health, mobile health. Seeing a trend? While the fancy names and technologies are grabbing the [...]

The Supreme Court unanimously voted today that genes isolated from the human body cannot be patented. The decision has been dubbed one of the “most significant rulings in the age of molecular [...]

Although recent media buzz around the Supreme Court has focused predominantly on high-profile social issues like Prop 8 and DOMA, pharmaceutical and biotech industry players have good reason to [...]